Diabetic patients with COVID-19: low antibody levels linked to worse outcomes Post author: Post published:October 30, 2023 Post category:uncategorized The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D. You Might Also Like Study: Drug-involved overdose deaths increased by over 500% in 2022 August 5, 2024 Alzheimer’s disease linked to disrupted brain oxygenation and neuronal function February 3, 2025 Challenging the chronic brain disease model of addiction July 1, 2024